# QBiotics

Source: https://onco.cc/companies/qbiotics/  
OnCo record `qbiotics` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

QBiotics is a Australia-based biotechnology company running 2 late-stage cancer trials in sarcomas and head and neck squamous cell carcinoma.

## Summary

QBiotics, based in Toowong, Brisbane, Australia, is a biotechnology company. QBiotics discovers and develops novel cell-signalling small molecules using phenotypic screening, with programmes in oncology, wound healing and antibiotic discovery. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials in sarcomas and head and neck squamous cell carcinoma. The largest, NCT05755113 (A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma), plans to enrol 40 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Also known as: QBiotics Group Limited
- Tags: ctgov-sponsor
- HQ: Toowong, Brisbane
- Type: biotech
- Website: https://www.qbiotics.com/

## Sources

- Official website: https://www.qbiotics.com/
- ClinicalTrials.gov: trials led by QBiotics: https://clinicaltrials.gov/search?lead=QBiotics%20Group%20Limited

## Connected records

- cancers: [Head and neck squamous cell carcinoma](https://onco.cc/cancers/head-and-neck/), [Sarcomas (soft tissue, bone, GIST)](https://onco.cc/cancers/sarcoma/)
- trials: [A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma](https://onco.cc/trials/nct05755113/), [A Clinical Study to Investigate the Efficacy of Tigilanol Tiglate Directly in Head and Neck Cancer](https://onco.cc/trials/nct05608876/)

---
JSON: https://onco.cc/api/v1/entities/qbiotics.json